Sam Frame
@SamuelRFrame
General Manager - UK & Ireland for Fisher & Paykel Healthcare. All views are my own.
You might like
Chief Investigator Arthur Kwizera shares an overview of the #ARISEAFRICA trial after presenting at #CCRdownunder and highlights what clinicians can take away from the results. Livestream -> criticalcarereviews.com @JAMA_current
Help shape the future of intensive care research - complete this survey to have your say on which questions research should answer about adult intensive care. surveymonkey.com/r/7SMGHPZ
Control oxygen from the device. High-pressure oxygen input allows precise FiO2 adjustment directly on the device. bit.ly/3L1Ub2a F&P, Optiflow, and Airvo are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see fphcare.com/ip.
➡️ Same therapy. ➡️ New interface. ➡️ Enhanced respiratory support.1 The Optiflow Duet high flow interface is asymmetrical, with one small and one large prong. To learn why we designed it this way, click here bit.ly/4eqnMPe. Tatkov S, et al. 2023.
Introducing the Airvo 3 simulator app. Explore a user interface simulation, navigate the menu system, and confidently test settings. qr.fph.co/bf8lc6 Not available in all countries.
Attending #aarccongress2024? An evolution in our understanding of high flow therapy over two decades has resulted in the F&P Optiflow Duet™ Asymmetric™ interface. Come and learn about the Optiflow Duet interface at booth #611 or find out more here bit.ly/4hUoUNx
Over the past two decades, our understanding of high flow therapy has evolved, resulting in the F&P Optiflow Duet™ Asymmetric interface. Learn more on our website bit.ly/3AMBii5
➡️ Same therapy. ➡️ New interface. ➡️ Enhanced respiratory support.1 Using an asymmetric design, one small prong and one large prong, we get a dual benefit. Learn more bit.ly/4cK1lTQ 1. Tatkov S, et al. J AppI Physiol. 2023.
Introducing the Airvo 3. An integrated battery gives you 40 minutes* to get your patients moving. bit.ly/4cCfovo *typical running time F&P, Optiflow, and Airvo are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see fphcare.com/ip.
A focus of the Airvo 3 has been the creation of a menu system that allows quick selection and adjustment of therapy settings bit.ly/3VXCUgS F&P, Optiflow, and Airvo are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see fphcare.com/ip
In December, we go to Melbourne! In association with the Alfred ICU Academic Centre (@intensiveblog) we're heading to The Edge in Fed Square, at the heart of the city If you're interested in clinical trials, join us to discuss the best critical care trials in the world Thanks…
Critical Care Reviews... Down Under! • LITFL Hard not to get excited about this - Rob Mac Sweeney is bringing the @CritCareReviews meeting to Melbourne, Dec 10th & 11th 2024. Don’t miss out… Register your EOI to attend! litfl.com/critical-care-…
It's Critical Care Reviews Meeting week 🚩 🔵 11 major trial results 🔵 Full, free livestream 🔵 No registration or login required - just go to the CCR homepage doi.org/criticalcarere… 🔴 #CCR24 disseminating science for all The Best Critical Care Trials in the World
Symposium from Fisher & Paykel Healthcare at #CCR24 Prof Milind Sovani @msovani - Pioneering Respiratory Support for Type 2 Respiratory Failure Wednesday, June 12th, 1pm Andrews Gallery, level 2, Titanic Belfast Livestream at criticalcarereviews.com @fphcare @OptiflowNHF
A very special couple of days. What a privilege to be in a room with this wonderful group #Optiflow @fphcare @lung_live4eva @Crimillina @msovani @Drbenmesser @JacquiPolington @NiamhOMalley @liam_campbell85 @walkwalkrun @DanLasserson @MatthewJQuint @PaulTwose @NickHartGSTT et al..
Introducing the Airvo™ 3 nasal high flow therapy system. An integrated battery enables 40 mins* of operating time to facilitate transport and patient mobilization throughout the hospital environment, minimizing therapy interruption. *typical operating time.
💥 The #RENOVATEtrial is finished at 1.8k pts recruited, as per design RENOVATE has no fixed sample size rather it had a sample size cap of 2k pts + triggers for success & futility analyzed by an independent DSMB Huge thanks to pts, families, recruiting centers +
How are you raising awareness today for #WorldCOPDDay? How can we identify #COPD earlier to make more of an impact on disease burden? It's time to expand the horizon of COPD and recognize lung function is an integral part of overall health in all stages of life. For more…
🚀Ready to change the game in mechanical ventilation? Join our team to develop cutting-edge solutions for personalised mechanical ventilation! We're looking for a passionate #PhD candidate to make a real impact. For more details, check here: warwick.ac.uk/fac/sci/eng/po… #PhDPosition
Reflecting on a brilliant few days @RCEMevents #RCEMasc. Inspiring to meet clinicians at the forefront of improving care and delivering research in Emergency Medicine. @fphcare #Optiflow #NasalHighFlow
Today's paper of the day is by Domenico Luca Grieco on non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS criticalcarereviews.com/latest-evidenc…
United States Trends
- 1. Good Thursday N/A
- 2. #Crew11 N/A
- 3. Hobbs N/A
- 4. #SpaceX N/A
- 5. Dragon N/A
- 6. Walt N/A
- 7. #NYGiants N/A
- 8. AI Summary N/A
- 9. #Zetarium N/A
- 10. #AEWDynamite N/A
- 11. NFC East N/A
- 12. AJ Dybantsa N/A
- 13. Jalen Brunson N/A
- 14. Deadpool N/A
- 15. Hubert N/A
- 16. Ghanaian N/A
- 17. AFCON N/A
- 18. Koa Peat N/A
- 19. Stanford N/A
- 20. Chukwueze N/A
Something went wrong.
Something went wrong.